What is the Return on Assets (ROA) of Immuron this year?
The Return on Assets (ROA) of Immuron is -0.17 undefined this year.
Immuron ROA 2024
Immuron ROA
-0.17
Ticker
IMC.AX
ISIN
AU000000IMC7
WKN
A0RDPK
In 2024, Immuron's return on assets (ROA) was -0.17, a 49.96% increase from the -0.11 ROA in the previous year.
Immuron Aktienanalyse
What does Immuron do?
Immuron Ltd was founded in 1994 and is headquartered in Melbourne, Australia. The company specializes in researching, developing, and marketing immunotherapy products. Immuron utilizes its patented technologies to develop and manufacture polyclonal antibodies and hyperimmune serums. The business model of Immuron focuses on selling immunotherapy products. The company concentrates on developing innovative products that address high medical needs and significantly improve the health of patients. Immuron operates in three divisions: gastrointestinal health, veterinary medicine, and infection control. Within these divisions, Immuron offers a variety of products tailored to specific needs. Gastrointestinal health is one of Immuron's key divisions. The company utilizes its expertise to develop products that protect and strengthen the human and animal intestine. Products in the gastrointestinal division include Travelan®, which is used for the prevention and treatment of traveler's diarrhea, and IMM-124E, which is used to treat inflammatory bowel diseases. It is also available in veterinary medicine. Veterinary medicine is another important pillar of Immuron's business. The company offers products tailored to the needs of animals. One notable product is the Immuron Canine® product line, used in the treatment of diarrhea in dogs. Additionally, the company has developed application-oriented research programs in infection control to aid veterinarians in improving the health of their animals. Immuron also has a division focused on infection control. The company develops and manufactures therapeutic products that target infections such as Helicobacter pylori and C. difficile. These products can contribute to reducing the use of antibiotics and antibiotic resistance. Over the years, Immuron has successfully brought several products to market. For example, Travelan® has been approved in Australia, Europe, and North America. Additionally, IMM-124E has been successfully tested in clinical studies in Canada and the United States and is currently undergoing the approval process in Europe. Overall, the company has a promising pipeline of products ready for market launch or phase II and III trials. These products have the potential to improve healthcare and enhance the quality of life for patients worldwide. Immuron has a strong foundation in immunotherapy research, which benefits the company in developing novel therapeutic options. Currently, Immuron is in a phase of growth, and it is likely that the company will achieve further success in the future. Immuron ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Immuron's Return on Assets (ROA)
Immuron's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Immuron's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Immuron's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Immuron’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Immuron stock
What was the ROA of Immuron compared to the previous year?
The ROA of Immuron has increased by 49.96% compared to the previous year.
What consequences do high ROA have for investors of Immuron?
A high ROA is advantageous for investors of Immuron, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Immuron?
A low ROA can be unfavorable for investors of Immuron as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Immuron affect the company?
An increase in ROA of Immuron can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Immuron impact the company?
A reduction in the ROA of Immuron can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Immuron?
Some factors that can influence the ROA of Immuron include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Immuron important for investors?
The ROA of Immuron is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Immuron take to improve ROA?
To improve ROA, Immuron can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Immuron pay?
Over the past 12 months, Immuron paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Immuron is expected to pay a dividend of 0 AUD.
What is the dividend yield of Immuron?
The current dividend yield of Immuron is .
When does Immuron pay dividends?
Immuron pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Immuron?
Immuron paid dividends every year for the past 0 years.
What is the dividend of Immuron?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Immuron located?
Immuron is assigned to the 'Health' sector.
Wann musste ich die Aktien von Immuron kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Immuron from 9/12/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.
When did Immuron pay the last dividend?
The last dividend was paid out on 9/12/2024.
What was the dividend of Immuron in the year 2023?
In the year 2023, Immuron distributed 0 AUD as dividends.
In which currency does Immuron pay out the dividend?
The dividends of Immuron are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Immuron
Our stock analysis for Immuron Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immuron Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
